View in EDS

Surrogate end points in oncology: aligning drug development incentives and patient needs.

Saved in:
Bibliographic Details
Title: Surrogate end points in oncology: aligning drug development incentives and patient needs.
Authors: Vogel M; John F. Kennedy School of Government, Harvard University, Cambridge, MA, USA. mvogel@hks.harvard.edu., Yaeger R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stewart DJ; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada., Subbiah V; Early Phase Drug Development Program, Sarah Cannon Research Institute, Nashville, TN, USA., David FS; Department of Biology, Tufts University, Medford, MA, USA.; Pharmagellan LLC, Milton, MA, USA.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Aug; Vol. 22 (8), pp. 617-618.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40481327
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Surrogate end points in oncology: aligning drug development incentives and patient needs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vogel+M%22">Vogel M</searchLink>; John F. Kennedy School of Government, Harvard University, Cambridge, MA, USA. mvogel@hks.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Yaeger+R%22">Yaeger R</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+DJ%22">Stewart DJ</searchLink>; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Early Phase Drug Development Program, Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22David+FS%22">David FS</searchLink>; Department of Biology, Tufts University, Medford, MA, USA.; Pharmagellan LLC, Milton, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101500077%22">Nature reviews. Clinical oncology</searchLink> [Nat Rev Clin Oncol] 2025 Aug; Vol. 22 (8), pp. 617-618.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101500077 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1759-4782 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217594774%22">17594774 </searchLink><i>NLM ISO Abbreviation: </i>Nat Rev Clin Oncol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40481327
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41571-025-01031-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 617
    Titles:
      – TitleFull: Surrogate end points in oncology: aligning drug development incentives and patient needs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vogel M
      – PersonEntity:
          Name:
            NameFull: Yaeger R
      – PersonEntity:
          Name:
            NameFull: Stewart DJ
      – PersonEntity:
          Name:
            NameFull: Subbiah V
      – PersonEntity:
          Name:
            NameFull: David FS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1759-4782
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Nature reviews. Clinical oncology
              Type: main
ResultId 1